Fresh Tracks Therapeutics Financials

Fresh Tracks Stock Summary

Fresh Tracks competes with Assembly Biosciences, Instil Bio, Nuvation Bio, Achilles Therapeutics, and NextCure. Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Fresh Tracks operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Fresh Tracks Key Financial Ratios

Fresh Tracks' financial ratios allow both analysts and investors to convert raw data from Fresh Tracks' financial statements into concise, actionable information that can be used to evaluate the performance of Fresh Tracks over time and compare it to other companies across industries.

Fresh Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fresh Tracks's current stock value. Our valuation model uses many indicators to compare Fresh Tracks value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresh Tracks competition to find correlations between indicators driving Fresh Tracks's intrinsic value. More Info.Fresh Tracks Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fresh Tracks by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fresh Tracks' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Fresh Tracks Market Pulse

Along with financial statement analysis, the daily predictive indicators of Fresh Tracks help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fresh Tracks Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fresh Tracks Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Fresh Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fresh Tracks's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.